top of page

Welcome to Trylle Biologics

 

We are merging biology and digital technology with innovative use of engineered human collagen in AI-driven medical devices and new neural interfaces.

​

At Trylle Biologics, we are dedicated to advancing healthcare through the integration of innovative biocompatible materials and cutting-edge digital technology. Our pioneering work focuses on developing medical devices and solutions using human-derived collagen, engineered from fibroblast cells in scalable bioreactors. This core technology serves as the foundation for our diverse product portfolio, driving new standards in personalized care and secure data management.

​

Our Technology

Human Collagen Manufacturing

Our proprietary platform produces high-purity, biocompatible human collagen, a critical component in all our medical devices. By utilizing engineered fibroblast cells, we generate extracellular matrix (ECM) proteins that enhance the functionality and compatibility of our products. This advanced technology allows us to create versatile medical solutions that address a wide range of healthcare needs.

​

​

​

​

​

​

​

​

​

​

Innovative Products

CareWidget

CareWidget is our flagship product, revolutionizing patient care and secure identification. By integrating human collagen with AI-powered check-in agents, CareWidget offers personalized, real-time healthcare solutions. This device seamlessly interfaces with existing Electronic Health Record (EHR) systems, improving workflow efficiency and enhancing patient outcomes.

 

 

 

 

 

RevolutionCheck

RevolutionCheck is a comprehensive SaaS platform designed for secure identification and data management. Paired with CareWidget, it offers a robust solution for healthcare providers, financial institutions, and military applications. Leveraging AI and blockchain technology, RevolutionCheck ensures the safe storage and transmission of sensitive information, setting new benchmarks in data security.

 

Brain-Machine Interface (BMI)

Our cutting-edge Brain-Machine Interface (BMI) technology represents the next frontier in medical innovation. Utilizing our human collagen platform, this device enhances neural interfaces, enabling groundbreaking applications in neurology and prosthetics. Our BMI technology aims to improve tissue integration, reduce immune response, and offer long-lasting solutions for patients with complex medical needs

​

Product Spotlight: Prostate Cancer Hydrogel Spacer

 

An essential step in Trylle Biologics’ product roadmap, the Prostate Cancer Hydrogel Spacer will be a 510(k)-cleared device designed to reduce radiation exposure to surrounding healthy tissues during prostate cancer treatment. This product strategically positions Trylle’s Human Collagen Biomaterials for FDA clearance, as it requires only animal studies rather than human clinical trials, expediting regulatory approval. The injectable spacer leverages Trylle’s Human Collagen Biomaterials to provide a high level of biocompatibility, offering a non-inflammatory, natural-tissue-like medium for safe, effective use in radiation therapy. This streamlined approval pathway for the hydrogel spacer serves as an entry point for Trylle to validate the safety, efficacy, and manufacturing capabilities of its products with the FDA. Success with this initial product will establish regulatory momentum and credibility, setting the stage for more complex applications such as BCIs and CareWidget.

 

By introducing the hydrogel spacer, Trylle can establish a scalable, FDA-compliant manufacturing process for its collagen biomaterials, positioning the company for expedited entry into the BCI and broader medtech markets. This proactive strategy underscores Trylle’s commitment to innovation, safety, and regulatory rigor as it pioneers the next wave of neural and medtech solutions.

​

At Trylle Biologics, we are not just creating products; we are shaping the future of healthcare. Our commitment to innovation, quality, and patient care drives everything we do. Whether you are a healthcare provider, investor, or partner, we invite you to join us on this exciting journey toward a healthier, more connected world.

 

Contact Us

For more information about our products, services, or investment opportunities, please reach out to us at info@trylleinc.com.

manufacturing human collagen in future.webp
collen-sem-blue.png

©2024 by Trylle, Inc.

bottom of page